Outcomes based on a 10-year post-interruption observation period a Estimates reflect OR across successive quarters prior to marketplace infliximab introduction b Estimates reflect the OR for the difference in intercept following marketplace infliximab introduction (immediate effect) c Estimates reflect the quarter-to-quarter difference in OR between the observed and expected slopes following marketplace infliximab introduction (gradual effect) d Estimates reflect the combined effects of differences in intercept and slope at the last observation quarter following marketplace infliximab introduction (observed minus counterfactual) Outcomes based on a 10-year post-interruption observation period a Estimates reflect OR across successive quarters prior to marketplace infliximab introduction b Estimates reflect the OR for the difference in intercept following marketplace infliximab introduction (immediate effect) c Estimates reflect the quarter-to-quarter difference in OR between the observed and expected slopes following marketplace infliximab introduction (gradual effect) d Estimates reflect the combined effects of differences in intercept and slope at the last observation quarter following marketplace infliximab introduction (observed minus counterfactual) Outcomes based on a 5-year post-interruption observation period a Estimates reflect OR across successive quarters prior to marketplace infliximab introduction b Estimates reflect the OR for the difference in intercept following marketplace infliximab introduction (immediate effect) c Estimates reflect the quarter-to-quarter difference in OR between the observed and expected slopes following marketplace infliximab introduction (gradual effect) d Estimates reflect the combined effects of differences in intercept and slope at the last observation quarter following marketplace infliximab introduction (observed minus counterfactual)
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